Nuzenio

Telomir Pharmaceuticals Inc

Telomir Pharmaceuticals Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez - MoomooMoomoo · Tue, 04 Aug 2026 12:05:14 GMTTelomir Pharmaceuticals Inc (TELO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTTelomir Pharmaceuticals Inc. (TELO) Q4 2025 Earnings: Wider-than-Expected Loss Amid Pre-Revenue R&D Stage - Profit Guidance Range - dars.gov.etdars.gov.et · Thu, 30 Jul 2026 13:37:14 GMTTelomir Pharmaceuticals, Inc. Common Stock (NASDAQ: TELO) Stock Price, News & Analysis - KalkineKalkine · Wed, 29 Jul 2026 12:23:44 GMTTelomir Pharmaceuticals (TELO) awards director 50,000 options at $1.34 exercise price - Stock TitanStock Titan · Mon, 27 Jul 2026 20:30:36 GMTTelomir Pharmaceuticals (TELO) grants 50,000 stock options to director - Stock TitanStock Titan · Mon, 27 Jul 2026 20:30:36 GMTTelomir Pharmaceuticals (TELO) awards director 50,000 stock options at $1.34 - Stock TitanStock Titan · Mon, 27 Jul 2026 20:30:36 GMTTELO|Telomir Pharmaceuticals Inc|Price:1.210|Chg%:-0.040 - TradingKeyTradingKey · Mon, 27 Jul 2026 13:23:15 GMT

Timeline

Tue, 04 Aug 2026 12:05:14 GMTTelomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez - Moomoo
Fri, 31 Jul 2026 07:00:00 GMTTelomir Pharmaceuticals Inc (TELO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Thu, 30 Jul 2026 13:37:14 GMTTelomir Pharmaceuticals Inc. (TELO) Q4 2025 Earnings: Wider-than-Expected Loss Amid Pre-Revenue R&D Stage - Profit Guidance Range - dars.gov.et
Wed, 29 Jul 2026 12:23:44 GMTTelomir Pharmaceuticals, Inc. Common Stock (NASDAQ: TELO) Stock Price, News & Analysis - Kalkine
Mon, 27 Jul 2026 20:30:36 GMTTelomir Pharmaceuticals (TELO) awards director 50,000 options at $1.34 exercise price - Stock Titan
Mon, 27 Jul 2026 20:30:36 GMTTelomir Pharmaceuticals (TELO) grants 50,000 stock options to director - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Telomir Pharmaceuticals Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.